Bausch Health Company Executives
BHC Stock | CAD 10.00 0.42 4.03% |
Bausch Health employs about 20.7 K people. The company is managed by 20 executives with a total tenure of roughly 14 years, averaging almost 0.0 years of service per executive, having 1035.0 employees per reported executive. Analysis of Bausch Health's management performance can provide insight into the firm performance.
Thomas Appio President President & Co-Head Bausch + Lomb/International |
Bausch |
Bausch Health Management Team Effectiveness
The company has return on total asset (ROA) of 0.0433 % which means that it generated a profit of $0.0433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (23.0454) %, meaning that it generated substantial loss on money invested by shareholders. Bausch Health's management efficiency ratios could be used to measure how well Bausch Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of March 2025, Return On Capital Employed is likely to grow to 0.10, though Return On Tangible Assets are likely to grow to (0). At this time, Bausch Health's Total Current Assets are very stable compared to the past year. As of the 25th of March 2025, Intangible Assets is likely to grow to about 5.8 B, while Total Assets are likely to drop about 15.4 B.As of the 25th of March 2025, Common Stock Shares Outstanding is likely to drop to about 251.2 M. In addition to that, Net Loss is likely to drop to about (212.6 M)
Bausch Health Workforce Comparison
Bausch Health Companies is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 142,698. Bausch Health retains roughly 20,700 in number of employees claiming about 15% of equities under Health Care industry.
Bausch Health Companies Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bausch Health Companies Price Series Summation is a cross summation of Bausch Health price series and its benchmark/peer.
Bausch Health Notable Stakeholders
A Bausch Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bausch Health often face trade-offs trying to please all of them. Bausch Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bausch Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Thomas Appio | President & Co-Head Bausch + Lomb/International | Profile | |
Mirza Dautbegovic | Executive COO | Profile | |
John Barresi | Controller, VP | Profile | |
Garen Sarafian | VP Relations | Profile | |
MSc MD | Chief VP | Profile | |
Jeff Hartness | Commercial Access | Profile | |
Kathleen Fitzpatrick | Executive Officer | Profile | |
Arthur Shannon | IR Contact Officer | Profile | |
Jiny MBA | Senior Medical | Profile | |
Tage MD | Chief RD | Profile | |
William Woodfield | Senior Treasurer | Profile | |
Donald Pearl | Senior Dermatologics | Profile | |
Robert Butz | VP Affairs | Profile | |
JeanJacques Charhon | Chief Officer | Profile | |
Aimee Lenar | Executive Pharma | Profile | |
Seana Carson | Executive Counsel | Profile | |
Josh Coyle | Senior Salix | Profile | |
Graham Jackson | Senior Officer | Profile | |
Thomas Vadaketh | Ex CFO | Profile | |
Cees Heiman | Senior Canada | Profile |
About Bausch Health Management Performance
The success or failure of an entity such as Bausch Health Companies often depends on how effective the management is. Bausch Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bausch management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bausch management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Capital Employed | 0.08 | 0.10 | |
Return On Equity | 0.04 | 0.03 |
Bausch Health Workforce Analysis
Traditionally, organizations such as Bausch Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bausch Health within its industry.Bausch Health Manpower Efficiency
Return on Bausch Health Manpower
Revenue Per Employee | 465K | |
Revenue Per Executive | 481.2M | |
Net Loss Per Employee | 2.2K | |
Net Loss Per Executive | 2.3M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.